Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$476,585
+$10,698 QoQ
Shares Held
3,041
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#908
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisory Services, LLC holds $45,032,363 across 13 Drug Manufacturers - General names. NVS ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,697 | $10,431,443 | |
| 2 | JNJ |
Johnson & Johnson
|
35,778 | $9,086,538 | |
| 3 | ABBV |
AbbVie Inc.
|
35,075 | $8,826,273 | |
| 4 | PFE |
Pfizer Inc
|
200,077 | $4,817,854 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,988 | $3,853,458 | |
| 6 | AMGN |
Amgen Inc
|
8,846 | $3,203,313 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,911 | $1,896,331 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,218 | $785,582 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $476,585 | 3,041 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $465,887 | 3,050 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $444,768 | 3,226 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $418,318 | 3,262 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $393,161 | 3,249 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $362,087 | 3,248 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $304,774 | 3,132 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $361,162 | 3,140 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $342,162 | 3,214 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $312,437 | 3,230 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $332,393 | 3,292 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $368,223 | 3,615 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $371,046 | 3,677 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $324,392 | 3,526 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $384,652 | 4,240 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $329,883 | 4,340 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $390,866 | 4,624 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $403,299 | 4,596 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $390,990 | 4,470 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $373,652 | 4,569 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $402,733 | 4,414 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $387,993 | 4,539 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $447,409 | 4,738 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $404,190 | 4,648 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $438,359 | 5,019 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $386,690 | 4,690 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||